During the past decade, Riverview Medical Center/Booker Cancer Center conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 29 clinical trials were completed, i.e. on average, 152.6% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 16 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Riverview Medical Center/Booker Cancer Center" #1 sponsor was "National Cancer Institute (NCI)" with 27 trials, followed by "Eastern Cooperative Oncology Group" with 12 trials sponsored, "SWOG Cancer Research Network" with 10 trials sponsored, "Alliance for Clinical Trials in Oncology" with 7 trials sponsored and "Fox Chase Cancer Center" with 7 trials sponsored. Other sponsors include 25 different institutions and companies that sponsored additional 23 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Riverview Medical Center/Booker Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 57 trials as a collaborator, "Cancer and Leukemia Group B" with 9 trials as a collaborator, "NRG Oncology" with 8 trials as a collaborator, "Eastern Cooperative Oncology Group" with 7 trials as a collaborator and "NCIC Clinical Trials Group" with 7 trials as a collaborator. Other collaborators include 38 different institutions and companies that were collaborators in the rest 27 trials.

According to Clinical.Site data, the most researched conditions in "Riverview Medical Center/Booker Cancer Center" are "Breast Cancer" (10 trials), "Lung Cancer" (10 trials), "Recurrent Squamous Cell Lung Carcinoma" (8 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials) and "Lymphoma" (5 trials). Many other conditions were trialed in "Riverview Medical Center/Booker Cancer Center" in a lesser frequency.

Most popular intervention types in "Riverview Medical Center/Booker Cancer Center" are "Drug" (67 trials), "Other" (41 trials), "Biological" (31 trials), "Radiation" (24 trials) and "Procedure" (16 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (29 trials), "Quality-of-Life Assessment" (14 trials), "cisplatin" (9 trials), "radiation therapy" (9 trials) and "Carboplatin" (8 trials). Other intervention names were less common.

The vast majority of trials in "Riverview Medical Center/Booker Cancer Center" are 70 trials for "All" genders, 20 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Riverview Medical Center/Booker Cancer Center". undefined are not yet recruiting, 8 are recruiting, 25 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 52 completed trials in Riverview Medical Center/Booker Cancer Center, 1 suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Riverview Medical Center/Booker Cancer Center, 1 "Phase 1" clinical trials were conducted, 28 "Phase 2" clinical trials and 56 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 6 trials that are defined as “Not Applicable".